Financials
- Market Capitalization 20.48 M
- Employee 29
- Founded 1986
- CEO Carl Spana
- Website www.palatin.com
- Headquarter New Jersey, United States
- FIGI BBG000BN9PY4
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
4.79
Rapporto prezzo/fatturato
1.91
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4539 | LEXX Lexaria Bioscience Corp. - Common Stock | 12.48 USD | +11.93% | +6.67% | +111.53% | +1302.25% | 20.62 M USD | ||
| 4543 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.79 USD | +0.80% | -1.81% | -1.81% | -68.42% | 20.48 M USD | ||
| 4545 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 12.63 USD | -8.28% | -8.41% | -1.33% | +115.90% | 20.45 M USD | ||
| 4548 | ENLV Enlivex Ltd. - Ordinary Shares | 1.28 USD | 0.00% | -15.79% | -40.19% | +19.63% | 20.26 M USD |